Patent Assignment
Reel/Frame 073889/0196
Merger
Recorded: 2026-02-25
Pages: 5
Assignor
DURECT CORPORATION
Executed: 2026-01-21
Assignee
MEDICIS PHARMACEUTICAL CORPORATION
400 SOMERSET CORPORATE BLVD, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(27)
Use of Oxygenated Cholesterol Sulfates for Treating at Least One of Insulin Resistance, Diabetes, and Prediabetes
Controlled delivery system
Depot Formulations
Injectable Controlled Release Composition Comprising High Viscosity Liquid Carrier
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof and at Least One Cyclic Oligosaccharide
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof and at Least One Cyclic Oligosaccharide
Sustained Release Drug Delivery Systems with Reduced Impurities and Related Methods
Sustained Release Drug Delivery Systems with Reduced Impurities and Related Methods
Sustained Release Drug Delivery Systems and Related Methods
Sucrose Acetate Isobutyrate Compositions with Low Peroxide Content
25-Hydroxy-Cholest-5-En-3-Sulfate Choline, Formulations Thereof and Methods for Preparing, and Uses of Same
Application:
19/142,082 →
Publication:
US US20260207628A1
Salts Including Crystalline Salts of 25-Hydroxy-Cholest-5-En-3-Sulfate and Methods for Preparing Same
Application:
19/142,096 →
Sustained Release Drug Delivery Systems and Related Methods
Application:
19/334,386 →
Publication:
US US20260137670A1
Treatment of Alcoholic Hepatitis
Application:
19/364,999 →
Publication:
US US20260102410A1
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Application:
18/115,286 →
Publication:
US US20230310458A1
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide
Application:
19/011,381 →
Publication:
US US20250249021A1
Crystalline and Liquid Crystalline 25-Hydroxy-Cholest-5-En-3-Sulfate Sodium and Methods for Preparing Same
25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, Same
Application:
18/572,715 →
Publication:
US US20240425545A1
Treatment of Non-Alcoholic Steatohepatitis (Nash)
Application:
17/924,101 →
Publication:
US US20230181601A1
Treatment of Non-Alcoholic Steatohepatitis (Nash)
Application:
17/924,103 →
Publication:
US US20230181602A1
Use of Oxygenated Cholesterol Sulfates for Treating Inflammatory Conditions
Application:
18/008,605 →
Publication:
US US20230372361A1
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2015
From: WRIGHT, JEREMY; TAMRAZ, WILMA; LEONARD, JOHN J; GIBSON, JOHN W
To: DURECT CORPORATION
Reel/Frame 036957/0842 →
Assignment of Assignor's Interest
Nov 4, 2015
From: WRIGHT, JEREMY C; THEEUWES, FELIX; GIBSON, JOHN W; BRANHAM, KEITH E
To: DURECT CORPORATION
Reel/Frame 036962/0478 →
Assignment of Assignor's Interest
Jun 21, 2016
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 038971/0172 →
Assignment of Assignor's Interest
Jan 4, 2017
From: ZOOGENIX
To: DURECT CORPORATION
Reel/Frame 040847/0001 →
Assignment of Assignor's Interest
Feb 6, 2017
From: WRIGHT, JEREMY; THEEUWES, FELIX; GIBSON, JOHN W; BRANHAM, KEITH
To: DURECT CORPORATION
Reel/Frame 041185/0366 →
Assignment of Assignor's Interest
Jul 30, 2019
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 049906/0155 →
Assignment of Assignor's Interest
Sep 10, 2019
From: CORPORATION, ALZA
To: DURECT CORPORATION
Reel/Frame 050327/0382 →
Assignment of Assignor's Interest
Sep 10, 2019
From: JUNNARKAR, GUNJAN; DESJARDIN, MICHAEL A.; CARR, JOHN PATRICK
To: ALZA CORPORATION
Reel/Frame 050327/0113 →
Assignment of Assignor's Interest
Mar 9, 2021
From: REN, SHUNLIN; XU, LEYUAN; NING, YANXIA; KIM, JIN KOUNG
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 055531/0983 →
Assignment of Assignor's Interest
Mar 17, 2021
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 055626/0551 →
Assignment of Assignor's Interest
Jan 10, 2022
From: MIKSZTAL, ANDREW R; JOICE, JUDY; AUTIO, SUSAN; DAVIS, MARK
To: DURECT CORPORATION
Reel/Frame 058613/0117 →
Assignment of Assignor's Interest
May 23, 2022
From: LEE, MIN L.; MIKSZTAL, ANDREW R.
To: DURECT CORPORATION
Reel/Frame 059990/0067 →
Assignment of Assignor's Interest
Jun 30, 2022
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: VIRGINIA COMMONWEALTH UNIVERSITY; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 060376/0928 →
Assignment of Assignor's Interest
Sep 15, 2022
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: VIRGINIA COMMONWEALTH UNIVERSITY; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 061108/0840 →
Assignment of Assignor's Interest
Sep 15, 2022
From: REN, SHUNLIN; XU, LEYUAN; NING, YANXIA; KIM, JIN KOUNG
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 061108/0782 →
Assignment of Assignor's Interest
Jan 9, 2023
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS; VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 062318/0868 →
Assignment of Assignor's Interest
Apr 6, 2023
From: MIKSZTAL, ANDREW R.; JOICE, JUDY; AUTIO, SUSAN; DAVIS, MARK
To: DURECT CORPORATION
Reel/Frame 063244/0462 →
Merger
Feb 19, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073837/0231 →
Security Interest
Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 074223/0753 →
Security Interest
Mar 30, 2026
From: MEDICIS PHARMACEUTICAL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0509 →